International Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -830 | -6,069 | -4,680 | -2,516 | -3,084 |
| Depreciation Amortization | 68 | 326 | 248 | 165 | 82 |
| Accounts receivable | -474 | 109 | -110 | -31 | -41 |
| Accounts payable and accrued liabilities | 782 | -11 | 57 | -431 | -111 |
| Other Working Capital | 638 | -266 | -163 | -177 | 30 |
| Other Operating Activity | -232 | 3,769 | 2,999 | 1,660 | 2,553 |
| Operating Cash Flow | $-48 | $-2,142 | $-1,649 | $-1,330 | $-571 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -57 | -112 | -89 | -60 | -8 |
| Purchase Sale Intangibles | -144 | -752 | -562 | -423 | -155 |
| Other Investing Activity | -144 | -752 | -562 | -423 | -155 |
| Investing Cash Flow | $-201 | $-864 | $-651 | $-483 | $-163 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 350 | 2,700 | 2,700 | 2,000 | 1,300 |
| Common Stock Issued | 90 | 500 | N/A | N/A | 0 |
| Other Financing Activity | -48 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $392 | $3,200 | $2,700 | $2,000 | $1,300 |
| Beginning Cash Position | 304 | 110 | 110 | 110 | 110 |
| End Cash Position | 447 | 304 | 510 | 297 | 676 |
| Net Cash Flow | $143 | $194 | $400 | $187 | $566 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48 | -2,142 | -1,649 | -1,330 | -571 |
| Capital Expenditure | -57 | -112 | -89 | -60 | -8 |
| Free Cash Flow | -105 | -2,254 | -1,738 | -1,390 | -579 |